Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Fate Therapeutics describes novel immune cell modulation compositions

Aug. 17, 2017

GlaxoSmithKline identifies novel ingenol derivatives

Aug. 16, 2017

Novel apoptosis regulator Bcl-2 inhibitors patented by Newave Pharmaceutical

Aug. 16, 2017

Vitae Pharmaceuticals divulges new nuclear receptor ROR-gamma modulators

Aug. 16, 2017

Shanghai Institute of Organic Chemistry identifies novel IDO-1 inhibitors

Aug. 16, 2017

Takeda Pharmaceutical presents novel mGluR7 agonists

Aug. 16, 2017

Novel S1P5 agonists identified at Ono Pharmaceutical

Aug. 14, 2017

Jiangsu Hansoh Pharmaceutical, Shanghai Hansoh Biomedical patents bile acid receptor antagonists

Aug. 14, 2017

New Bruton tyrosine kinase inhibitors patented by InnoCare Pharma

Aug. 14, 2017

NEOMED Institute presents bromodomain and extraterminal domain protein inhibitors

Aug. 14, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...